Bank of America
PDLI

Bank of America’s PDL BioPharma, Inc. PDLI Stock Holding History

Bank of America’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-38,671
Closed -$122K – 7632
2020
Q3 		$122K Sell
38,671
-9,920
-20% -$31.7K ﹤0.01% 5581
2020
Q2 		$141K Buy
48,591
+1,583
+3% +$5.01K ﹤0.01% 5480
2020
Q1 		$132K Sell
47,008
-2,708
-5% -$8.73K ﹤0.01% 5361
2019
Q4 		$161K Sell
49,716
-56,914
-53% -$165K ﹤0.01% 5754
2019
Q3 		$230K Sell
106,630
-241,008
-69% -$644K ﹤0.01% 5584
2019
Q2 		$1.09M Sell
347,638
-904,570
-72% -$2.93M ﹤0.01% 4506
2019
Q1 		$4.66M Buy
1,252,208
+969,804
+343% +$3.27M ﹤0.01% 3234
2018
Q4 		$818K Buy
282,404
+191,079
+209% +$525K ﹤0.01% 4566
2018
Q3 		$240K Sell
91,325
-726,686
-89% -$1.78M ﹤0.01% 5388
2018
Q2 		$1.91M Buy
818,011
+687,139
+525% +$1.92M ﹤0.01% 4011
2018
Q1 		$384K Sell
130,872
-74,211
-36% -$203K ﹤0.01% 5002
2017
Q4 		$561K Buy
205,083
+53,008
+35% +$163K ﹤0.01% 4872
2017
Q3 		$516K Sell
152,075
-1,653,107
-92% -$4.6M ﹤0.01% 4929
2017
Q2 		$4.46M Buy
1,805,182
+1,661,638
+1,158% +$3.82M ﹤0.01% 3142
2017
Q1 		$326K Buy
143,544
+23,698
+20% +$52.4K ﹤0.01% 5099
2016
Q4 		$254K Buy
119,846
+19,735
+20% +$55.1K ﹤0.01% 5210
2016
Q3 		$335K Sell
100,111
-201,795
-67% -$641K ﹤0.01% 4880
2016
Q2 		$949K Buy
301,906
+78,479
+35% +$262K ﹤0.01% 4229
2016
Q1 		$744K Sell
223,427
-264,184
-54% -$824K ﹤0.01% 4318
2015
Q4 		$1.73M Sell
487,611
-33,748
-6% -$141K ﹤0.01% 3927
2015
Q3 		$2.62M Sell
521,359
-2,176
-0.4% -$12.5K ﹤0.01% 3516
2015
Q2 		$3.37M Buy
523,535
+932
+0.2% +$6.24K ﹤0.01% 2958
2015
Q1 		$3.68M Sell
522,603
-4,352,725
-89% -$31.5M ﹤0.01% 2735
2014
Q4 		$37.6M Buy
4,875,328
+606,295
+14% +$4.8M 0.01% 1002
2014
Q3 		$31.9M Buy
4,269,033
+2,317,156
+119% +$21.5M 0.01% 1105
2014
Q2 		$18.9M Sell
1,951,877
-684,442
-26% -$6.1M 0.01% 1443
2014
Q1 		$21.9M Sell
2,636,319
-79,441
-3% -$681K 0.01% 1229
2013
Q4 		$22.9M Sell
2,715,760
-610,239
-18% -$5.14M 0.01% 1230
2013
Q3 		$26.5M Buy
3,325,999
+509,988
+18% +$4.1M 0.01% 1070
2013
Q2 		$21.7M Buy
+2,816,011
New +$22M 0.01% 1140

Other funds holding PDLI

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.46% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Bank of America's PDLI Position: Q4 2020 in Review

Bank of America sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 38,671 shares — an estimated $122K sold.

Bank of America first reported a position in PDLI in Q2 2013 and held it in 30 quarters. The position peaked at $37.6M in Q4 2014. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • Bank of America reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • Bank of America sold 38,671 PDL BioPharma, Inc. shares in Q4 2020, an estimated $122K.
  • Bank of America first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 30 quarters.
  • Bank of America's PDL BioPharma, Inc. position peaked at $37.6M in Q4 2014.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Bank of America's 13F filing for Q4 2020, filed 10 Feb 2021.